Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02948452 · ClinicalTrials.gov registry record

Anxiety and Reward Interaction and Prediction of Outcomes in Anorexia Nervosa

A clinical trial of Anxiety and Anorexia Nervosa, Restricting Type, sponsored by University of California, Los Angeles.

Completed
Registry status
66
Enrollment target
1
Study location

NCT02948452: Completed study of Anxiety and Anorexia Nervosa, Restricting Type, sponsored by University of California, Los Angeles.

NCT02948452 is a study of Anxiety and Anorexia Nervosa, Restricting Type that has completed, run by University of California, Los Angeles. The registered enrollment target is 66 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02948452, a study of Anxiety and Anorexia Nervosa, Restricting Type, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
66 participants
Enrollment target
1
Study location

Study Summary

This study is designed to understand responsiveness to reward in adolescents with restricting-type anorexia nervosa compared with non-clinical controls, and how it is affected by potential-threat perception.

Primary Outcome

Mean BOLD percentage signal change between anxiety and control conditions will be compared across anorexia nervosa and comparison participants during the reward task

Interventions

  • OTHER fMRI

Study Locations (1)

California

  • UCLA - Los Angeles

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2015-11
Est. Completion 2021-06-30

What the finished NCT02948452 record still lists

NCT02948452 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (85% lower).

The record links to 2 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which fMRI is the first listed.

NCT02948452 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02948452 about?

NCT02948452 is a clinical study titled "Anxiety and Reward Interaction and Prediction of Outcomes in Anorexia Nervosa". This study is designed to understand responsiveness to reward in adolescents with restricting-type anorexia nervosa compared with non-clinical controls, and how it is affected by potential-threat perception.

What is the current status of trial NCT02948452?

This trial is currently completed. The enrollment target is 66 participants. The study started on 2015-11. Estimated completion is 2021-06-30.

What conditions does trial NCT02948452 study?

This clinical trial studies the following conditions: Anxiety, Anorexia Nervosa, Restricting Type.

What interventions are being tested in trial NCT02948452?

The interventions under investigation include: fMRI (OTHER).

Who is sponsoring clinical trial NCT02948452?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02948452 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02948452's enrollment target sits among peer trials

66 221st of 364 higher than 142 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02584244 · 66 participants · Phase 1

    Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers

  • NCT03067051 · 66 participants · Phase 1

    Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System

  • NCT03754725 · 66 participants · Phase 1

    Ferritin and Iron Burden in SAH sIRB

  • NCT03875378 · 66 participants · Phase 2

    Transdermal Estrogen in Women With Anorexia Nervosa

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02948452, the US trial registry maintained by the National Library of Medicine. NCT02948452 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.